Features | Partner Sites | Information | LinkXpress
Sign In
BioConferenceLive
JIB
GLOBETECH PUBLISHING

Debate Resolved on Human Cell Shut-Down Mechanisms

By BiotechDaily International staff writers
Posted on 25 Apr 2012
Researchers have resolved the controversy over the mechanisms involved in the shutdown process during cell division in the body.

The investigators, from the University of Liverpool (UK), published their findings April 2012 in the journal Proceeding of the National Academy of Sciences of the USA (PNAS), may contribute to future research on how scientists could modify this shut-down process to ensure that viruses and other pathogens do not enter the cells of the body and cause harm.

Earlier studies had shown that when cells divide, they cannot execute any other task apart from this one. They cannot, for example, take in food and fluids at the same time as managing the important process of dividing into “daughter cells” to replicate the body’s genetic data. Instead, cells, shut-down the intake of food and fluid during cell division, and for many years it was thought that they did this by preventing a receptor from moving nutrients through the cell membrane.

Recently, scientists have provided evidence to suggest that this hypothesis may be wrong. Scientists have contended that the cell does not shut down the processes that allow food and fluid to enter the cell as previously believed, but rather the receptors that transport this fuel are absent altogether during cell division, allowing the cell to focus on the one task of dividing.

Studies at Liverpool, however, have now shown that the original concept, first documented in 1965, is accurate. The receptors are present and able to transport food and fluid during cell division, but the mechanism that allows them through the membrane of the cell shuts-down until cell division is complete.

Dr. Stephen Royle, from the University’s Institute of Translational Medicine, explained, “We know that cells in the body do not have the ability to multitask during cell division. It can only focus on the job of dividing and not on other important tasks such as uptake of nutrients. If we think of the cell membrane like a dock at a port and the receptors as a boat delivering cargo, we have shown that the boat, or receptor, is present but the dock, or membrane, does not allow it to unload or go any further. Viruses and pathogens use the same route into cells as nutrients, so the next stage of this work is to identify the trigger for this shutdown process, so that we understand whether this on/off switch can be manipulated to prevent harmful infections passing through the cell membrane. This is a long way in the future, but this work puts us closer to understanding how the cells in the body work.”

Related Links:

University of Liverpool



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

Molecular Pathway Decreases Cell Adhesion and Initiates Metastasis

A recent paper outlined a molecular pathway that enables lung cancer cells to migrate away from the site of the primary tumor and become established in other parts of the body. Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) linked a virtual alphabet soup of genes and their protein products... Read more

Drug Discovery

view channel
Image: Molecular rendering of the crystal structure of parkin (Photo courtesy of Wikimedia Commons).

Cinnamon Feeding Blocks Development of Parkinson's Disease in Mouse Model

A team of neurological researchers has identified a molecular mechanism by which cinnamon acts to protect neurons from damage caused by Parkinson's disease (PD) in a mouse model of the syndrome.... Read more

Therapeutics

view channel

Vaccine Being Developed for Heart Disease Close to Reality

The world’s first vaccine for heart disease is becoming a possibility with researchers demonstrating significant arterial plaque reduction in concept testing in mice. Klaus Ley, MD, from the La Jolla Institute for Allergy and Immunology (LA Jolla, CA, USA), and a vascular immunology specialist, is leading the vaccine... Read more

Business

view channel

A Surge in IPOs Revitalize Investments for the Global Pharma and Biotech

Anti-infective drugs, oncology, and pharmaceutical contract laboratories attract the most investment up to now. The intensified private equity and venture capital (PEVC) deal activity in the global healthcare industry during the recession years, 2008–2010, witnessed a waning post-2010. However, the decline in deals... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.